| 2022 |
Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm
10.1093/eurheartj/ehac056
Authors: S. Hageman, A. McKay, P. Ueda, L. Gunn, T. Jernberg, E. Hagström, D. Bhatt, P. Steg, K. Läll, R. Mägi, Nordbø Gynnild, H. Ellekjær, I. Saltvedt, J. Tuñón, I. Mahíllo, Á Aceña, K. Kaminski, M. Chlabicz, E. Sawicka, T. Tillman, J. McEvoy, E. Di Angelantonio, I. Graham, D. De Bacquer, K. Ray, J. Dorresteijn, F. Visseren |
| 2022 |
Effectiveness of bisoprolol versus other β-blockers and other antihypertensive classes: a cohort study in the Clinical Practice Research Datalink
10.2217/cer-2021-0305
Authors: C. Foch, A. Allignol, T. Hohenberger, E. Boutmy, S. Schaefer, U. Hostalek |
| 2022 |
Blood eosinophils to guide inhaled maintenance therapy in a primary care COPD population
10.1183/23120541.00606-2021
Authors: H. Ashdown, M. Smith, E. McFadden, I. Pavord, C. Butler, M. Bafadhel |
| 2022 |
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Anaphylactic Reaction Among Patients With Type 2 Diabetes: Multisite Population-Based Cohort Study
10.1093/aje/kwac021
Authors: R. Pradhan, E. Patorno, H. Tesfaye, S. Schneeweiss, H. Yin, J. Franklin, A. Pawar, C. Santella, O. H. Y. Yu, C. Renoux, L. Azoulay |
| 2022 |
Observational retrospective study calculating health service costs of patients receiving surgery for chronic rhinosinusitis in England, using linked patient-level primary and secondary care electronic data
10.1136/bmjopen-2021-055603
Authors: C. Clarke, E. Williamson, S. Denaxas, J. Carpenter, M. Thomas, H. Blackshaw, A. Schilder, C. Philpott, C. Hopkins, S. Morris |
| 2022 |
Long-Term patterns of cancer incidence among patients with and without type 2 diabetes in the United Kingdom
10.1016/j.diabres.2022.109229
Authors: R. Pradhan, O. Yu, R. Platt, L. Azoulay |
| 2022 |
The feasibility of pragmatic influenza vaccine randomized controlled real-world trials in Denmark and England
10.1038/s41541-022-00444-6
Authors: J. Nealon, D. Modin, R. Ghosh, D. Rudin, G. Gislason, H. Booth, J. Jensen, R. Williams, H. Shepherd, E. Yelland, H. Bricout, S. Chaves, T. Biering-Sørensen |
| 2022 |
Has the gout epidemic peaked in the UK? A nationwide cohort study using data from the Clinical Practice Research Datalink, from 1997 to across the COVID-19 pandemic in 2021
10.1136/annrheumdis-2021-221989
Authors: A. Abhishek, L. Tata, M. Mamas, A. Avery |
| 2022 |
Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK
10.1136/bmjdrc-2021-002517
Authors: T. Weiss, L. Yang, R. Carr, S. Pal, B. Sawhney, R. Boggs, S. Rajpathak, K. Iglay |
| 2022 |
Opioid use prior to total knee replacement: comparative analysis of trends in England and Sweden
10.1016/j.joca.2022.02.621
Authors: D. Yu, C. Hellberg, T. Appleyard, A. Dell'Isola, G. Thomas, A. Turkiewicz, M. Englund, G. Peat |
| 2022 |
The risk of all-cause and cause-specific mortality in people prescribed mirtazapine: an active comparator cohort study using electronic health records
10.1186/s12916-022-02247-x
Authors: R. Joseph, R. Jack, R. Morriss, R. Knaggs, D. Butler, C. Hollis, J. Hippisley-Cox, C. Coupland |
| 2022 |
Screening for type 2 diabetes after a diagnosis of gestational diabetes by ethnicity: A retrospective cohort study
10.1016/j.pcd.2022.03.008
Authors: E. Vounzoulaki, K. Khunti, J. Miksza, B. Tan, M. Davies, C. Gillies |
| 2022 |
Effectiveness and safety of apixaban vs. rivaroxaban in patients with atrial fibrillation and type 2 diabetes mellitus
10.1055/a-1798-2116
Authors: Roy Chowdhury, J. Michaud, O. H. Y. Yu, H. Yin, L. Azoulay, C. Renoux |
| 2022 |
UK poSt Arthroplasty Follow-up rEcommendations (UK SAFE): what does analysis of linked, routinely collected national data sets tell us about mid-late term revision risk after hip replacement? Retrospective cohort study
10.1136/bmjopen-2021-050877
Authors: L. Smith, C. Garriga, S. Kingsbury, R. Pinedo-Villanueva, A. Delmestri, N. Arden, M. Stone, P. Conaghan, A. Judge |
| 2022 |
Primary care and cancer: an analysis of the impact and inequalities of the COVID-19 pandemic on patient pathways
10.1136/bmjopen-2021-059374
Authors: T. Watt, R. Sullivan, A. Aggarwal |
| 2022 |
Reduction of Cardiovascular Disease and Mortality versus Risk of New Onset Diabetes with Statin Use in Patients with Rheumatoid Arthritis
10.1002/acr.24866
Authors: G. Ozen, S. Dell'Aniello, S. Pedro, K. Michaud, S. Suissa |
| 2022 |
Epidemiology of invasive meningococcal disease and sequelae in the United Kingdom during the period 2008 to 2017 - a secondary database analysis
10.1186/s12889-022-12933-3
Authors: S. Guedes, H. Bricout, E. Langevin, S. Tong, I. Bertrand-Gerentes |
| 2022 |
Serum potassium variability as a predictor of clinical outcomes in patients with cardiorenal disease or diabetes: a retrospective UK database study
10.1093/ckj/sfab225
Authors: G. James, J. Kim, C. Mellström, K. Ford, N. Jenkins, C. Tsang, M. Evans, P. McEwan |
| 2022 |
Intra-abdominal cancer risk with abdominal pain: a prospective cohort primary care study
10.3399/bjgp.2021.0552
Authors: S. Price, N. Gibson, W. Hamilton, A. King, E. Shephard |
| 2022 |
Effects of ACE inhibitors and angiotensin receptor blockers: protocol for a UK cohort study using routinely collected electronic health records with validation against the ONTARGET trial
10.1136/bmjopen-2021-051907
Authors: P. Baptiste, A. Wong, A. Schultze, M. Cunnington, J. Mann, C. Clase, C. Leyrat, L. Tomlinson, K. Wing |
| 2022 |
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and risk of depression among older people with hypertension
10.1177/02698811221082470
Authors: T. van Sloten, P. Souverein, C. Stehouwer, J. Driessen |
| 2022 |
Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis
10.1136/bmj-2021-068373
Authors: X. Li, B. Raventós, E. Roel, A. Pistillo, E. Martinez-Hernandez, A. Delmestri, C. Reyes, V. Strauss, D. Prieto-Alhambra, E. Burn, T. Duarte-Salles |
| 2022 |
Changes in heart failure management and long-term mortality over 10 years: observational study
10.1136/openhrt-2021-001888
Authors: A. Bottle, R. Newson, P. Faitna, B. Hayhoe, M. Cowie |
| 2022 |
Characteristics of New Users of Aclidinium Bromide, Aclidinium/Formoterol, and Other COPD Medications in the United Kingdom, Denmark, and Germany
10.1007/s40261-022-01120-2
Authors: E. Rivero-Ferrer, M. Olesen, E. Plana, J. Aguado, N. Saigi-Morgui, A. Rubino, S. Daoud, A. Lei, S. Perez-Gutthann, T. Schink, N. Kristiansen, J. Hallas, A. Pottegard, C. Rebordosa |
| 2022 |
Primary care clinical management following self-harm during the first wave of COVID-19 in the UK: population-based cohort study
10.1136/bmjopen-2021-052613
Authors: S. Steeg, M. Carr, L. Trefan, D. Ashcroft, N. Kapur, E. Nielsen, B. McMillan, R. Webb |
| 2022 |
Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes
10.2337/dc21-1113
Authors: A. Wright, M. Carr, E. Kontopantelis, L. Leelarathna, H. Thabit, R. Emsley, I. Buchan, M. Mamas, T. van Staa, N. Sattar, D. Ashcroft, M. Rutter |
| 2022 |
Associations between multiple long-term conditions and mortality in diverse ethnic groups
10.1371/journal.pone.0266418
Authors: M. Stafford, H. Knight, J. Hughes, A. Alarilla, L. Mondor, Pefoyo Kone, W. Wodchis, S. Deeny |
| 2022 |
Impact of covid-19 on primary care contacts with children and young people aged 0-24 years in England; longitudinal trends study 2015-2020
10.3399/BJGP.2021.0643
Authors: K. Foley, E Maile, A. Bottle, F. Neale, R. Viner, S. Kenny, A. Majeed, D. Hargreaves, S. Saxena |
| 2022 |
Therapies for Long COVID in non-hospitalised individuals: from symptoms, patient-reported outcomes and immunology to targeted therapies (The TLC Study)
10.1136/bmjopen-2021-060413
Authors: S. Haroon, K. Nirantharakumar, S. Hughes, A. Subramanian, O. Aiyegbusi, E. Davies, P. Myles, T. Williams, G. Turner, J. Chandan, C. McMullan, J. Lord, D. Wraith, K. McGee, A. Denniston, T. Taverner, L. Jackson, E. Sapey, G. Gkoutos, K. Gokhale, E. Leggett, C. Iles, C. Frost, G. McNamara, A. Bamford, T. Marshall, D. Zemedikun, G. Price, S. Marwaha, N. Simms-Williams, K. Brown, A. Walker, K. Jones, K. Matthews, J. Camaradou, M. Saint-Cricq, S. Kumar, Y. Alder, D. Stanton, L. Agyen, M. Baber, H. Blaize, M. Calvert |
| 2022 |
Does Cardiovascular Mortality Overtake Cancer Mortality During Cancer Survivorship?: An English Retrospective Cohort Study
10.1016/j.jaccao.2022.01.102
Authors: H. Strongman, S. Gadd, A. Matthews, K. Mansfield, S. Stanway, A. Lyon, I. dos-Santos-Silva, L. Smeeth, K. Bhaskaran |
| 2022 |
Fluticasone-Based versus Budesonide-Based Triple Therapies in COPD: Real-World Comparative Effectiveness and Safety
10.1080/15412555.2022.2035705
Authors: S. Suissa, S. Dell'Aniello, P. Ernst |
| 2022 |
Discontinuation of Inhaled Corticosteroids from Triple Therapy in COPD: Effects on Major Outcomes in Real World Clinical Practice
10.1080/15412555.2022.2045265
Authors: S. Suissa, S. Dell'Aniello, P. Ernst |
| 2022 |
Associations of Cardiovascular and Non-Cardiovascular Comorbidities with Dementia Risk in Patients with Diabetes: Results from a Large UK Cohort Study
10.14283/jpad.2022.8
Authors: B. Zheng, B. Su, C. Udeh-Momoh, G. Price, I. Tzoulaki, E. Vamos, A. Majeed, E. Riboli, S. Ahmadi-Abhari, L. Middleton |
| 2021 |
Adverse outcomes after partner bereavement in people with reduced kidney function: Parallel cohort studies in England and Denmark
10.1371/journal.pone.0257255
Authors: P. Bidulka, S. Vestergaard, A. Hlupeni, A. Kjaersgaard, A. Wong, S. Langan, S. Schmidt, S. Lyon, C. Christiansen, D. Nitsch |
| 2021 |
Assessing the severity of cardiovascular disease in 213 088 patients with coronary heart disease: a retrospective cohort study
10.1136/openhrt-2020-001498
Authors: S. Zghebi, M. Mamas, D. Ashcroft, M. Rutter, H. VanMarwijk, C. Salisbury, C. Mallen, C. Chew-Graham, N. Qureshi, S. Weng, T. Holt, I. Buchan, N. Peek, S. Giles, D. Reeves, E. Kontopantelis |
| 2021 |
Assessment of common infections and incident dementia using UK primary and secondary care data: a historical cohort study
10.1016/s2666-7568(21)00118-5
Authors: R. Muzambi, K. Bhaskaran, L. Smeeth, C. Brayne, N. Chaturvedi, C. Warren-Gash |
| 2021 |
Associations between attainment of incentivised primary care diabetes indicators and mortality in an English cohort
10.1016/j.diabres.2021.108746
Authors: A. McKay, L. Gunn, E. Vamos, J. Valabhji, G. Molina, M. Molokhia, A. Majeed |
| 2021 |
Associations between breast cancer survivorship and adverse mental health outcomes: A matched population-based cohort study in the United Kingdom
10.1371/journal.pmed.1003504
Authors: H. Carreira, R. Williams, G. Funston, S. Stanway, K. Bhaskaran |
| 2021 |
Asthma phenotyping in primary care: applying the International Severe Asthma Registry eosinophil phenotype algorithm across all asthma severities
10.1016/j.jaip.2021.07.056
Authors: M. Kerkhof, T. Tran, R. Allehebi, G. Canonica, L. Heaney, M. Hew, Perez de Llano, M. Wechsler, L. Bulathsinhala, V. Carter, I. Chaudhry, N. Eleangovan, R. Murray, C. Price, D. Price |
| 2021 |
Atopic eczema in adulthood and mortality: UK population-based cohort study, 1998-2016
10.1016/j.jaci.2020.12.001
Authors: R. Silverwood, K. Mansfield, A. Mulick, A. Wong, S. Schmidt, A. Roberts, L. Smeeth, K. Abuabara, S. Langan |
| 2021 |
Atopic-eczema-associated fracture risk and oral corticosteroids: a population-based cohort study
10.1016/j.jaip.2021.09.026
Authors: J. Matthewman, K. Mansfield, D. Prieto-Alhambra, A. Mulick, L. Smeeth, K. Lowe, R. Silverwood, S. Langan |
| 2021 |
Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study
10.1136/bmj.n1435
Authors: X. Li, A. Ostropolets, R. Makadia, A. Shoaibi, A. Rao, A. Sena, E. Martinez-Hernandez, K. Verhamme, P. Rijnbeek, P.B. Ryan, D. Prieto-Alhambra |
| 2021 |
Characterization and Associated Costs of Constipation Relating to Exposure to Strong Opioids in England: An Observational Study
10.1016/j.clinthera.2021.03.021
Authors: C. Morgan, S. Jenkins-Jones, R. Knaggs, C. Currie, P. Conway, C. Poole, E. Berni |
| 2021 |
A Cohort Study to Evaluate the Risk of Hospitalisation for Congestive Heart Failure Associated with the Use of Aclidinium and Other Chronic Obstructive Pulmonary Disease Medications in the UK Clinical Practice Research Datalink
10.2147/copd.s301624
Authors: C. Rebordosa, E. Plana, A. Rubino, J. Aguado, A. Lei, S. Daoud, N. Saigi-Morgui, S. Perez-Gutthann, E. Rivero-Ferrer |
| 2021 |
Comorbid diseases and conditions in people with HIV in the UK
10.1080/03007995.2021.2003671
Authors: B. Jones, A. Freedman, M. Thomas, C. Villalba-Mendez, L. Sathia, D. Flanagan, S. Francis, C. Currie |
| 2021 |
Comparative differences in musculoskeletal pain consultation and analgesic prescription for people with dementia: a UK-wide matched cohort study
10.1097/j.pain.0000000000002257
Authors: L. Bullock, J. Bedson, Y. Chen, C. Chew-Graham, P. Campbell |
| 2021 |
Comparative Effectiveness of Initial LAMA versus LABA in COPD: Real-World Cohort Study
10.1080/15412555.2021.1877649
Authors: S. Suissa, S. Dell'Aniello, P. Ernst |
| 2021 |
Comparing initial LABA-ICS inhalers in COPD: Real-world effectiveness and safety
10.1016/j.rmed.2021.106645
Authors: S. Suissa, S. Dell'Aniello, P. Ernst |
| 2021 |
Comparison of Pregnancy Outcomes of Patients Treated With Ondansetron vs Alternative Antiemetic Medications in a Multinational, Population-Based Cohort
10.1001/jamanetworkopen.2021.5329
Authors: C. Dormuth, B. Winquist, A. Fisher, F. Wu, P. Reynier, S. Suissa, M. Dahl, Z. Ma, X. Lu, J. Zhang, C. Raymond, K. Filion, R. Platt, C. Moriello, J. Paterson |
| 2021 |
The Complex Association Between Bariatric Surgery and Depression: a National Nested-Control Study
10.1007/s11695-020-05201-z
Authors: C. Arhi, R. Dudley, O. Moussa, M. Ardissino, S. Scholtz, S. Purkayastha |
